Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
Activating oncogenic mutations in KRAS and NRAS are common in colorectal cancer, which is a heterogenous disease. Here, the authors show that the RAS mutation spectrum is markedly different between colon and rectal cancer, and also different based on age of diagnosis and microsatellite instability.
Main Authors: | Ilya G. Serebriiskii, Caitlin Connelly, Garrett Frampton, Justin Newberg, Matthew Cooke, Vince Miller, Siraj Ali, Jeffrey S. Ross, Elizabeth Handorf, Sanjeevani Arora, Christopher Lieu, Erica A. Golemis, Joshua E. Meyer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-11530-0 |
Similar Items
-
A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system
by: Golemis Erica A, et al.
Published: (2004-04-01) -
Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers.
by: Laura B Kleiman, et al.
Published: (2013-01-01) -
Synchronous Adenocarcinoma of the Colon and Rectal Carcinoid
by: Vamshidhar Vootla, et al.
Published: (2016-10-01) -
Neonatal Rectal Colonization with Malassezia furfur
by: Gil J Gross, et al.
Published: (1992-01-01) -
The practical implications of K-ras mutations in the colon
by: Martin, John Paul
Published: (2002)